| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $21.8M | -26.7% |
| Cost of Revenue | $9.9M | -17.2% |
| Gross Profit | $11.8M | -33.1% |
| R&D Expense | $21.7M | -7.9% |
| SG&A Expense | $10.6M | +6.3% |
| Operating Income | -$20.4M | -29.3% |
| Pre-tax Income | -$20.0M | -28.3% |
| Income Tax | $70K | -81.2% |
| Net Income | -$20.1M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.4M | -47.0% |
| Accounts Receivable | $3.1M | -10.2% |
| Inventory | $5.0M | -22.4% |
| Current Assets | $30.1M | -28.1% |
| Total Assets | $42.5M | -29.1% |
| Current Liabilities | $5.4M | -25.5% |
| Total Liabilities | $6.5M | -23.6% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.4M | -3.0% |
| Capital Expenditures | $645K | +104.1% |
| Investing Cash Flow | $2.8M | -58.7% |
| Financing Cash Flow | $1.8M | +349.5% |
| Free Cash Flow | -$18.0M | -4.9% |
| -25.7% |
| EPS (Basic) | -$0.80 | -23.1% |
| EPS (Diluted) | -$0.80 | -23.1% |
| Stockholders' Equity |
| $36.0M |
| -30.0% |